Phenotypic evaluation of the affected participants in this study defines MYMK-CFZS as a congenital myopathy with marked facial weakness and additional clinical and pathologic features that distinguish it from other congenital neuromuscular syndromes and from Moebius syndrome. This evidence concerns the gene MYMK and congenital myopathy.